Over the first eight months of 2021, exports of the capital’s pharmaceutical products and medical devices amounted to $819.39 million, which is almost four times more than in the same period of 2019. This was announced on Tuesday, November 16, on the official website of the mayor of Moscow.
“Today Moscow is the center of the pharmaceutical industry in Russia and the leading exporter of products of this sector. The capital accounts for about 40% of the volume of supplies of medical equipment and slightly more than 52% of pharmaceutical products. The combined exports of these two directions increased from $207.11 million in the first eight months of 2019 to $819.39 million in January-August 2021,” commented Vladimir Efimov, Deputy Mayor of Moscow for Economic Policy and Property and Land Relations.
According to him, this year Moscow has sold pharmaceutical products to 114 countries, which is 17 more than last year. The main buyers were Argentina, India, Mexico, the United Arab Emirates, Italy, as well as neighboring countries. Medical devices have been exported to 92 countries this year. The main buyers were neighboring countries and partners from Europe: the Netherlands, Germany, and France.
“According to the results of eight months of 2021, Moscow’s exports of medical products amounted to over $69 million, which is 39% more than in the same period of 2020, and 32% more than in 2019. Moscow has increased the volume of exports of medical industry products due to a steady growth of the supply of CT scanners, catheters, and similar products,” added Alexander Prokhorov, head of the capital’s Department of Investment and Industrial Policy.
As the head of the department stressed, in the eight months of 2021, Moscow’s pharmaceutical exports exceeded $ 750 million. This is 3.5 times more than in the same period in 2020, and almost five times more than in 2019. It became possible to increase the volume of exports of pharmaceutical products due to a growth of the supply of various vaccines, as well as by expanding the range of other pharmaceutical products. This includes packaged medicines and immunological products.